Fosamax
Product Images NDC 54868-4384

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Fosamax (NDC 54868-4384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Of 10 mg Package Label (10mg Package Label)

Image Of 10 mg Package Label (10mg Package Label)
This is a label of Fosamar 104g Tablets, distributed by Physicians Total Care with NDC number 54868-3857-0. It also includes the lot number, but the expiration date is not clear. The rest of the text seems to be either a barcode or product code and cannot be used for description.*
FDA Label Image

Image Of 35 mg Package Label (35mg Package Label)

Image Of 35 mg Package Label (35mg Package Label)
This is a product label. The product is distributed by Physicians Total Care and the lot number is 0680 with an expiration date of 6160. The rest of the information is not readable.*
FDA Label Image

Image Of 5 mg Package Label (5mg Package Label)

Image Of 5 mg Package Label (5mg Package Label)
This is a medication information label. The medication name is Fosare G, and it was distributed by Physicians Total Care. The NDC (National Drug Code) number is 54868-4384-0. The lot number is Yt ED, IE 010. The purpose or indication of the medication is not available, and neither are the directions for use or any further details.*
FDA Label Image

Image Of 70 mg Package Label (70mg Package Label)

Image Of 70 mg Package Label (70mg Package Label)
This is a package of medication containing Fosnark 76mg that is distributed by Physicians Total Care. The medication has an expiration date of 01780 and the package identification number is 44620040000.*
FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
FDA Label Image

Image Of Figure 1(osteoporosis Treatment Studies In Postmenopausal Women) (Figure 1)

Image Of Figure 1(osteoporosis Treatment Studies In Postmenopausal Women) (Figure 1)
FDA Label Image

Image Of Figure 2(osteoporosis Treatment Studies In Postmenopausal Women) (Figure 2)

Image Of Figure 2(osteoporosis Treatment Studies In Postmenopausal Women) (Figure 2)
FDA Label Image

Image Of Figure 3 (cumulative Incidence Of Hip Fractures) (Figure 3)

Image Of Figure 3 (cumulative Incidence Of Hip Fractures) (Figure 3)
FDA Label Image

Image Of Figure 4 (osteoporosis Prevention Studies) (Figure 4)

Image Of Figure 4 (osteoporosis Prevention Studies) (Figure 4)
FDA Label Image

Image Of Figure 5 (studies In Glucocorticoid-treated Patients) (Figure 5)

Image Of Figure 5 (studies In Glucocorticoid-treated Patients) (Figure 5)
FDA Label Image

Image Of Figure 6 (studies In Paget's Disease Of Bone) (Figure 6)

Image Of Figure 6 (studies In Paget's Disease Of Bone) (Figure 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.